CJC-1295 / Ipamorelin· 10 mg
- Sealed lyophilized vial, lot code on the label
- Same-day weekday shipping before 2PM ET
Ships as lyophilized powder for laboratory research use.
Need 10+ vials? Email sales@truebondlabs.com for wholesale pricing.
CJC-1295 / Ipamorelin in the literature
This combination vial pairs 5 mg of CJC-1295 (No DAC) with 5 mg of ipamorelin as a single lyophilized research product. CJC-1295 is a stabilized 29-amino-acid GRF analogue, while ipamorelin is a five-amino-acid synthetic compound characterized in the literature as a selective agonist of the ghrelin (growth hormone secretagogue) receptor. TrueBond Labs verifies both components in every batch through independent HPLC purity testing, enforcing a 99% minimum, and mass-spectrometry identity analysis prior to release.
The pairing is common in preclinical research because the two compounds act on complementary targets: laboratory investigations use them together when characterizing growth-hormone-axis signaling through both GHRH-receptor and ghrelin-receptor pathways in vitro. A fixed 5 mg/5 mg co-lyophilized format lets research teams document one lot number instead of two. These remarks describe study areas only; the product has no approved use and ships without any usage guidance.
The lot-specific certificate of analysis is available at /lab-reports under the vial's printed lot code, letting labs archive purity documentation alongside their own records. Stability follows our standard profile: −20°C for the sealed lyophilized vial across 24+ months.
All information is provided for educational context on laboratory research only and is not a claim of therapeutic effect. This product is not for human or animal use.
Product & terms of sale
Contents
CJC-1295 / Ipamorelin (10 mg), supplied as lyophilized powder for laboratory research applications.
Intended use
This product is sold strictly for in-vitro laboratory research by qualified professionals. It is not for human or animal consumption, and no usage instructions are provided or implied.
Legal disclaimer
Not evaluated or approved by the FDA. Nothing on this page constitutes a claim of therapeutic, diagnostic, or preventive benefit. See our full research disclaimer.
Terms of sale
By purchasing, you affirm you are a qualified researcher (21+) and accept our Terms & Conditions and research-use-only requirements.
CJC-1295 / Ipamorelin: frequently asked questions
What is the CJC-1295 / ipamorelin combo?
It is a single 3 mL research vial containing 5 mg of CJC-1295 (No DAC) and 5 mg of ipamorelin co-lyophilized together, for 10 mg of combined compound content. CJC-1295 is a modified GRF (1-29) analogue and ipamorelin a selective ghrelin-receptor compound. The combo is manufactured exclusively for in-vitro laboratory research.
What role does ipamorelin play in this combo?
Ipamorelin is a synthetic compound (five amino acids) described in the scientific literature as a selective agonist at the growth hormone secretagogue (ghrelin) receptor. It is used in laboratory investigations of receptor selectivity within the growth-hormone axis. In this product it is supplied alongside CJC-1295 at a verified 5 mg quantity per vial.
How do I check the COA for this combo vial?
Find the lot code printed on your vial and look it up at /lab-reports to open the certificate directly. Each COA presents independent HPLC purity results (every released lot tests at 99% or above) together with mass-spectrometry identity confirmation for both compounds in the blend.
Can CJC-1295 and ipamorelin be ordered separately?
Yes. TrueBond Labs lists CJC-1295 (No DAC) 10 mg and ipamorelin 10 mg as standalone vials elsewhere in the catalog, each with its own lot documentation. The combo exists for laboratories that want both compounds drawn from a single verified batch at a fixed 5 mg/5 mg ratio; choosing between the formats depends entirely on how a given study is structured.